Acetate raw materials for injectable drug development

Pharmaceutical firms could look at using anhydrous sodium acetate and potassium acetate in some injectable formulations. The route of administration imposes stringent constraints on the quality and process control of the raw ingredients, industrial or standard food grade products cannot be utilised directly as excipients for injections.

Position of anhydrous sodium acetate in the formulation

The pH of formulations or formulations in development may be adjusted by mixing sodium acetate with a suitable acid. The appropriateness for infusions, small volume injections or freeze-dried goods depends on the stability of the drug, osmolality, control of impurities and other parameters.

Potassium acetate position in the formulation

Potassium acetate may be a source of potassium ions and acetate ions in certain electrolyte formulations or buffer systems. The potassium content, compatibility and safety of administration should be managed according to the formula and clinical usage of the intended therapeutic product. The constituent proportions of various injectable products should not be mixed.

Raw Material Quality Records

Pharmaceutical businesses should check data on relevant pharmacopeial standards, source of excipients, elemental impurities, microbiological limits, endotoxins and particle matter control. The term high purity does not ensure that the product meets all the standards for sterile preparations. Sterility assurance also relies on the formulation procedure.

​​​​​​​

Verification Content

Perform tests on drug compatibility, pH, osmolality, stability and packaging compatibility; complete assessment of excipient related information or verification of registration paperwork in line with relevant regulatory standards.